A case of reversible posterior leukoencephalopathy syndrome caused by transient hypercoagulable state induced by infection

Hypertension Research

Volumn 28, Issue 7, 2005, Pages 619-623

  Yano, Yuichiro ^a,b,d   Kario, Kazuomi ^b   Fukunaga, Takashi ^a   Ohshita, Tomohiko ^c   Himeji, Daisuke ^a   Yano, Michiko ^a   Nakagawa, Susumu ^a   Sakata, Yoichi ^b   Shimada, Kazuyuki ^b  

^a MIYAZAKI PREFECTURAL MIYAZAKI HOSPITAL   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d Nango National Health Insurance Hospital   (Japan)

Author keywords

Endothelial dysfunction; Hypercoagulable state; Normotensive; Reversible posterior leukoencephalopathy syndrome

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; D DIMER; HEPARIN; PLASMIN; PROSTACYCLIN; THROMBIN ANTITHROMBIN COMPLEX; WARFARIN;

AGED; ARTICLE; CARDIOMEGALY; CASE REPORT; CLINICAL FEATURE; CYANOSIS; ELECTROCARDIOGRAM; ENDOTHELIUM CELL; FEMALE; HEART MURMUR; HEMOSTASIS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERCOAGULABILITY; HYPOXIA; INFECTION; INTUBATION; LEUKOCYTE COUNT; LEUKOENCEPHALOPATHY; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL EDEMA; PULMONARY HYPERTENSION; RISK FACTOR; SINUS TACHYCARDIA; SWAN GANZ CATHETER; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; TRICUSPID VALVE REGURGITATION; VISUAL IMPAIRMENT;

AGED; BLOOD COAGULATION DISORDERS; BLOOD PRESSURE; BRAIN DISEASES; FEMALE; HUMANS; HYPERTENSIVE ENCEPHALOPATHY; INFECTION; MAGNETIC RESONANCE IMAGING;

EID: 25844517155     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.28.619     Document Type: Article

References (27)

1. Hinchey J, Chaves C, Appignani B, et al: A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334: 494-500.
2. Eguchi K, Kasahara K, Nagashima A, et al: Two cases of malignant hypertension with reversible diffuse leukoencephalopathy exhibiting a reversible nocturnal blood pressure "riser" pattern. Hypertens Res 2002; 25: 467-473.
3. Yong PF, Hamour SM, Burns A: Reversible posterior leukoencephalopathy in a patient with systemic sclerosis/systemic lupus erythematosus overlap syndrome. Nephrol Dial Transplant 2003; 18: 2660-2662.
4. Bakshi R, Shaikh ZA, Bates VE, Kinkel PR: Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients. Neurology 1999; 52: 1285-1288.
5. Verma S, Anderson TJ: Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002; 105: 546-549.
6. Bonetti PO, Lerman LO, Lerman A: Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168-175.
7. Furumoto T, Saito N, Dong J, Mikami T, Fujii S, Kitabatake A: Association of cardiovascular risk factors and endothelial dysfunction in Japanese hypertensive patients: implications for early atherosclerosis. Hypertens Res 2002; 25: 475-480.
8. Tomiyama H, Kushiro T, Okazaki R, Yoshida H, Doba N, Yamashina A: Influences of increased oxidative stress on endothelial function, platelets function, and fibrinolysis in hypertension associated with glucose intolerance. Hypertens Res 2003; 26: 295-300.
9. On YK, Kim CH, Oh BH, Lee MM, Park YB: Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension. Hypertens Res 2002; 25: 365-371.
10. Dong J, Fujii S, Goto D, et al: Increased expression of plasminogen activator inhibitor-1 by mediators of the acute phase response: a potential progenitor of vasculopathy in hypertensives. Hypertens Res 2003; 26: 723-729.
11. Dohi Y, Ohashi M, Sugiyama M, Takase H, Sato K, Ueda R: Circulating thrombomodulin levels are related to latent progression of atherosclerosis in hypertensive patients. Hypertens Res 2003; 26: 479-483.
12. Targonski PV, Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Lerman A: Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation 2003; 107: 2805-2809.
13. Perticone F, Ceravolo R, Pujia A, et al: Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191-196.
14. Okura Y, Takao M, Zhang B, Nakashima Y, Saku K: Cardiovascular risk factor profiles and endothelial function in coronary artery disease patients treated with statins. Hypertens Res 2004; 27: 723-729.
15. Iseki K, Kimura Y, Wakugami K, et al: Comparison of the effect of blood pressure on the development of stroke, acute myocardial infarction, and end-stage renal disease. Hypertens Res 2000; 23: 143-149.
16. Sacco RL, Ellenberg JH, Mohr JP, et al: Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989; 25: 382-390.
17. Li C, Engstrom G, Hedblad B, Berglund G, Janzon L: Risk factors for stroke in subjects with normal blood pressure: a prospective cohort study. Stroke 2005; 36: 234-238.
18. Casey SO, Sampaio RC, Michel E, Truwit CL: Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. Am J Neuroradiol 2000; 21: 1199-1206.
19. Eichler FS, Wang P, Wityk RJ, Beauchamp NJ Jr, Barker PB: Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. Am J Neuroradiol 2002; 23: 833-837.
20. Rosenberg RD, Aird WC: Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999; 340: 1555-1564.
21. Brown RC, Davis TP: Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke. Stroke 2002; 33: 1706-1711.
22. Wardlaw JM, Sandercock PA, Dennis MS, Starr J: Is break-down of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003; 34: 806-812.
23. Goldstein LB, Adams R, Becker K, et al: Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 2001; 32: 280-299.
24. Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P: Stroke. Lancet 2003; 362: 1211-1224.
25. Kario K, Matsuo T, Hoshide S, Umeda Y, Shimada K: Effect of thrombin inhibition in vascular dementia and silent cerebrovascular disease. An MR spectroscopy study. Stroke 1999; 30: 1033-1037.
26. Schachna L, Wigley FM: Targeting mediators of vascular injury in scleroderma. Curr Opin Rheumatol 2002; 14: 686-693.
27. Ay H, Buonanno FS, Schaefer PW, et al: Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998; 51: 1369-1376.